Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study

Published:2022-08 Issue:8 Volume:9 Page:e554-e562
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Molina Jean-Michel,Ghosn Jade,Assoumou Lambert,Delaugerre Constance,Algarte-Genin Michèle,Pialoux Gilles,Katlama Christine,Slama Laurence,Liegeon Geoffroy,Beniguel Lydie,Ohayon Michel,Mouhim Hanane,Goldwirt Lauriane,Spire Bruno,Loze Bénédicte,Surgers Laure,Pavie Juliette,Lourenco Jérémy,Ben-Mechlia Mohamed,Le Mestre Soizic,Rojas-Castro Daniela,Costagliola Dominique

Funder

Sidaction

Merck

ANRS

Île-de-France Regional Council

Gilead Sciences

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference24 articles.

1. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

2. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

3. HIV pre-exposure prophylaxis: scaling up for impact now and in the future;Bavinton;Lancet Public Health,2021

4. Getting to Zero San Francisco: a collective impact approach;Buchbinder;J Acquir Immune Defic Syndr,2019

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial;The Lancet Regional Health - Europe;2024-10

2. Pre-exposure prophylaxis (PrEP) use trajectories and incidence of HIV and other sexually transmitted infections among PrEP users in Belgium: a cohort analysis of insurance claims data from 2017 to 2019;BMC Public Health;2024-08-23

3. Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows non‐superiority for oral dosing, but promise as a subcutaneous implant;CPT: Pharmacometrics & Systems Pharmacology;2024-08-20

4. Interest in event-driven PrEP among men who have sex with men using daily PrEP in Mexico in 2019–2020: a cross-sectional assessment in a large-scale demonstration project;AIDS Care;2024-08-08

5. Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany;BMC Public Health;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3